These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29745540)

  • 1. [Recent progress in nanomedicine for hepatocellular carcinoma therapy].
    Xiong Q; Wang J; Bai Y; Song T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2018 Apr; 35(2):314-319. PubMed ID: 29745540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma.
    Liu T; Liu L; Li L; Cai J
    Mater Today Bio; 2023 Oct; 22():100766. PubMed ID: 37636988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment.
    Singh A; Shafi S; Upadhyay T; Najmi AK; Kohli K; Pottoo FH
    Curr Top Med Chem; 2020; 20(20):1839-1854. PubMed ID: 32579503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.
    Ladju RB; Pascut D; Massi MN; Tiribelli C; Sukowati CHC
    Oncotarget; 2018 Jan; 9(2):2951-2961. PubMed ID: 29416827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma.
    Elnaggar MH; Abushouk AI; Hassan AHE; Lamloum HM; Benmelouka A; Moatamed SA; Abd-Elmegeed H; Attia S; Samir A; Amr N; Johar D; Zaky S
    Semin Cancer Biol; 2021 Feb; 69():91-99. PubMed ID: 31421265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology for Hepatocellular Carcinoma: From Surveillance, Diagnosis to Management.
    Wu H; Wang MD; Liang L; Xing H; Zhang CW; Shen F; Huang DS; Yang T
    Small; 2021 Feb; 17(6):e2005236. PubMed ID: 33448111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma.
    Lu J; Wang J; Ling D
    Small; 2018 Feb; 14(5):. PubMed ID: 29251419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct stratification of normal liver, hepatocellular carcinoma (HCC), and anticancer nanomedicine-treated- tumor tissues by Raman fingerprinting for HCC therapeutic monitoring.
    Poojari R; Bhujbal M; Hole A; Murali Krishna C
    Nanomedicine; 2021 Apr; 33():102352. PubMed ID: 33418135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma.
    Hou XY; Jiang G; Yang CS; Tang JQ; Wei ZP; Liu YQ
    Recent Pat Anticancer Drug Discov; 2016; 11(3):322-31. PubMed ID: 26955964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma.
    Lu Y; Gao Y; Yang H; Hu Y; Li X
    Mil Med Res; 2022 Dec; 9(1):69. PubMed ID: 36503490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment.
    Bakrania A; Zheng G; Bhat M
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery system targeting advanced hepatocellular carcinoma: Current and future.
    Zhang X; Ng HLH; Lu A; Lin C; Zhou L; Lin G; Zhang Y; Yang Z; Zhang H
    Nanomedicine; 2016 May; 12(4):853-869. PubMed ID: 26772424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting.
    Alhalmi A; Beg S; Kohli K; Waris M; Singh T
    Curr Drug Targets; 2021; 22(7):779-792. PubMed ID: 33302831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting Early Diagnosis and Precise Therapy of Hepatocellular Carcinoma by Glypican-3-Targeted Synergistic Chemo-Photothermal Theranostics.
    Mu W; Jiang D; Mu S; Liang S; Liu Y; Zhang N
    ACS Appl Mater Interfaces; 2019 Jul; 11(26):23591-23604. PubMed ID: 31179679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
    Kumar V; Rahman M; Gahtori P; Al-Abbasi F; Anwar F; Kim HS
    Expert Opin Drug Deliv; 2021 Jun; 18(6):673-694. PubMed ID: 33295218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go.
    Wang K; Wang C; Jiang H; Zhang Y; Lin W; Mo J; Jin C
    Front Immunol; 2021; 12():792781. PubMed ID: 34975896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress.
    Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H
    Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
    Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
    Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.